Standard BioTools Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $111.2M | $264.8M | $21.7M |
| FY2020 | $185.7M | $324.8M | $68.5M |
| FY2021 | $180.6M | $275.2M | $28.5M |
| FY2022 | $160.5M | $390.3M | $81.3M |
| FY2023 | $159.9M | $323.1M | $51.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $111.2M | $264.8M | $21.7M |
| FY2020 | $185.7M | $324.8M | $68.5M |
| FY2021 | $180.6M | $275.2M | $28.5M |
| FY2022 | $160.5M | $390.3M | $81.3M |
| FY2023 | $159.9M | $323.1M | $51.7M |